NEW BRUNSWICK, N.J.--(BUSINESS WIRE)--
Johnson & Johnson (NYSE: JNJ) will participate in the 2023 Wells Fargo SecuritiesHealthcare Conference at the Encore Boston Harbor in Everett, MA on Thursday, September 7th. Ashley McEvoy, EVP, Worldwide Chairman, MedTech along with executives from Abiomed will represent the Company in a session scheduled at 10:15 a.m. (Eastern Time).
This conference call will be available to investors and other interested parties by visiting the Johnson & Johnson website at www.investor.jnj.com.
A webcast and podcast replay will be available approximately 48 hours after the live webcast.
View source version on businesswire.com:
https://www.businesswire.com/news/home/20230807587886/en/
Investor Contact:
RA-JJCUS-InvestorRel@ITS.JNJ.com
Media Contact:
media-relations@its.jnj.com
Source: Johnson & Johnson